SCHEMBL7931602

SCHEMBL7931602

Nc1ccn(C2COCS2)c(=O)n1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.49
PDE3A Q14432 3/20 0.49
CACNA1F O60840 2/20 0.49
ALB P02768 2/20 0.49
MAPT P10636 2/20 0.49
CACNA1D Q01668 2/20 0.49
CACNA1S Q13698 2/20 0.49
CACNA1C Q13936 2/20 0.49
THRB P10828 1/20 0.42
MTOR P42345 1/20 0.42
MDM2 Q00987 1/20 0.42
NCOA1 Q15788 1/20 0.42
NCOA3 Q9Y6Q9 1/20 0.42
PDE4D Q08499 1/20 0.40
SLC29A1 Q99808 1/20 0.40
POLG P54098 2/20 0.39
FGFR1 P11362 2/20 0.36
NT5E P21589 1/20 0.35
POLB P06746 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13881252 0.74 LMNA (0.44) LMNAPDE3ACACNA1FALBMAPT
SCHEMBL3965514 0.74 ALB (0.51) ALBPOLG
SCHEMBL10015810 0.74 LMNA (0.44) LMNAPDE3ACACNA1FALBMAPT
SCHEMBL16639144 0.74 LMNA (0.47) LMNAPDE3ACACNA1FALBMAPT
SCHEMBL12438758 0.73 LMNA (0.55) LMNAPDE3ACACNA1FALBMAPT
SCHEMBL1387739 0.73 LMNA (0.55) LMNAPDE3ACACNA1FALBMAPT
SCHEMBL6047863 0.73 LMNA (0.46) LMNAPDE3ACACNA1FALBMAPT
SCHEMBL7087937 0.72 LMNA (0.50) LMNAPDE3ACACNA1FALBMAPT
SCHEMBL1256522 0.72 LMNA (0.50) LMNAPDE3ACACNA1FALBMAPT
SCHEMBL16639146 0.72 ABL1 (0.56) LMNAMAPTNT5EPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1089741-A1 USE OF 3'-AZIDO-2',3'-DIDEOXYURIDINE IN COMBINATION WITH FURTHER ANTI-HIV DRUGS FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF HIV EMORY UNIVERSITY (US) 2001-04-11 EP disclosed
EP-1027061-A4 IMINE-FORMING POLYSACCHARIDES, PREPARATION THEREOF AND THE USE THEREOF AS ADJUVANTS AND IMMUNOSTIMULANTS GALENICA PHARMACEUTICALS INC (US) 2000-12-13 EP disclosed
EP-1027061-A1 IMINE-FORMING POLYSACCHARIDES, PREPARATION THEREOF AND THE USE THEREOF AS ADJUVANTS AND IMMUNOSTIMULANTS Galenica Pharmaceuticals, Inc. (US) 2000-08-16 EP disclosed
WO-1999066936-A9 USE OF 3'-AZIDO-2',3'-DIDEOXYURIDINE IN COMBINATION WITH FURTHER ANTI-HIV DRUGS FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF HIV UNIV EMORY (US) 2000-04-06 WO disclosed
WO-1999066936-A1 USE OF 3'-AZIDO-2',3'-DIDEOXYURIDINE IN COMBINATION WITH FURTHER ANTI-HIV DRUGS FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF HIV EMORY UNIVERSITY (US) 1999-12-29 WO disclosed
WO-1999017783-A1 IMINE-FORMING POLYSACCHARIDES, PREPARATION THEREOF AND THE USE THEREOF AS ADJUVANTS AND IMMUNOSTIMULANTS GALENICA PHARMACEUTICALS, INC. (US) 1999-04-15 WO disclosed
WO-1996028443-A1 THERAPEUTIC BENZOXAZOLES THE WELLCOME FOUNDATION LIMITED (GB) 1996-09-19 WO disclosed
EP-0728018-A1 THERAPY THE WELLCOME FOUNDATION LIMITED (GB) 1996-08-28 EP disclosed
WO-1995013095-A2 THERAPY THE WELLCOME FOUNDATION LIMITED (GB) 1995-05-18 WO disclosed